Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

ABSTRACTThe dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), are associated with clinical...

Full description

Bibliographic Details
Main Authors: Juan Meng, Guohui Xiao, Juanjuan Zhang, Xing He, Min Ou, Jing Bi, Rongqing Yang, Wencheng Di, Zhaoqin Wang, Zigang Li, Hong Gao, Lei Liu, Guoliang Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
COVID-19
hypertension
Renin-angiotensin system
angiotensin-converting enzyme inhibitors
angiotensin II type1 receptor blockers
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1746200

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2020.1746200

Similar Items